HyNOVA - A Randomised Study Comparing Hyperthermic and Normothermic Intraperitoneal Chemotherapy Following Interval Cytoreductive Surgery for Stage III Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Funding period: 2021 - 2023
Completed